Split, reduced, and living donor liver transplantation (LDLT) techniques have developed over the past 2 decades because of a shortage of size-matched liver grafts for pediatric recipients. These technical innovations have expanded the donor pool and decreased waitinglist mortality for children.
| INTRODUC TI ON
Split, reduced, and living donor liver transplantation (LDLT) techniques have developed over the past 2 decades because of a shortage of size-matched liver grafts for pediatric recipients. These technical innovations have expanded the donor pool and decreased waitinglist mortality for children. 1 However, when the graft-to-recipient weight ratio (GRWR) exceeds 4.0% in neonates and smaller infants receiving a left lateral segment (LLS) graft from an adult donor, the graft may be too large, which carries risks of morbidity. 2 To overcome this critical large-for-size graft problem, advanced techniques have been developed to further reduce the size of LLS grafts in pediatric LDLT, especially for neonates or smaller infants. [2] [3] [4] [5] [6] [7] [8] However, the anteroposterior thickness of grafts remains a problem, particularly in smaller children without portal hypertension, hepatomegaly, or ascites, most of whom do not have sufficient abdominal space to allow a thick graft to settle, because these techniques use nonanatomical reduction of the lateral or caudal part of the LLS, which cannot adequately reduce graft thickness. 9 Anatomically reduced LLS grafting has been reported as an alternative method for smaller infants and is known as a subsegment 2 graft or conventional reduced-thickness LLS graft. 10 Although this graft can reduce graft thickness, there are some technical disadvantages, mainly the risk of injury to the portal pedicle because of the need for dissection at the base of the umbilical fissure. Therefore, since 2014, we have introduced a modified reduction technique of the LLS, which we refer to as the modified segment 2 (S2) graft. 9, 11 However, there have been no studies to date of the long-term outcomes of pediatric LDLT patients who received reduced-thickness LLS grafts or large-scale studies of the effectiveness of the grafts.
In this retrospective study, we assessed short-term and longterm outcomes of LDLT using reduced-thickness LLS grafts compared with conventional nonanatomically reduced LLS (NAR-LLS)
grafts. We also examined the prognostic factors affecting graft survival and assessed graft regeneration rate in smaller children.
| PATIENTS AND ME THODS

| Patients
From November 2005 to January 2017, a total of 403 consecutive pediatric patients (< 18 years old) underwent LDLT at the National Center for Child Health and Development, Tokyo, Japan. Of these, 261 patients received an LLS graft and 96 patients received a reduced LLS graft.
After excluding 7 recipients who required graft reduction in situ during the recipient operation, 89 patients were enrolled in this study: 47
in the NAR-LLS graft group and 42 in the reduced-thickness LLS graft group (13 subsegment 2 grafts and 29 modified S2 grafts; Figure 1 ).
Immunosuppressive therapy consisted of tacrolimus and lowdose steroids. 12 Informed consent was obtained from all donors and recipients before enrollment and their anonymity was preserved.
The study was approved by the Ethics Committee of the National Center for Child Health and Development and conducted in accordance with the Declaration of Helsinki (2008).
| Graft selection
Until December 2012, we had selected NAR-LLS grafts as the only option for small infants when the estimated graft-to-recipient weight ratio (GRWR) exceeded 4.0%. 6, 7 Between January 2013 and July 2014, we accounted for the size and shape of the graft and considered using a reduced-thickness LLS graft when the ratio of the maximum thickness of the LLS to the anteroposterior diameter of the recipient's abdominal cavity was ≥ 1.0. When the ratio was < 1.0, we considered using the NAR-LLS graft. The algorithm during this period has been described previously. 9 Since September 2014, we have used the modified S2 graft as the first option although we have used NAR-LLS grafts when the donor grafts were extremely thin and adequate volume reduction could be achieved by NAR-LLS rather than modified S2 grafts. The current algorithm is shown in Figure 2A and the number of cases of each graft type over time is shown in Figure 2B .
In all donors, we assessed vascular anatomy and volumetry of the liver by using 3-dimensional computer models (Fraunhofer MEVIS, Bremen, Germany).
| Surgical procedure
| Conventional NAR-LLS grafts (Figure 3A)
These grafts have been referred to as monosegment grafts or hyperreduced LLS grafts. 2, 7, 8 The donor LLS was reduced in situ as described previously. 2, 7 Both the caudal and lateral parts of the LLS were resected in situ while preserving the medial branch of the left hepatic vein.
| Reduced-thickness LLS grafts
Subsegment 2 grafts (Figure 3B)
After isolation of the LLS graft, portal vein (PV) feeding segment 3
([S3] P3) was exposed, and the relevant PV branches feeding the reduced part of S3 were occluded to make demarcation lines on the surface between S2 and S3. 9 The portal venous flow to the graft F I G U R E 1 Flow diagram of the patients included in this study.
was routinely confirmed using intraoperative Doppler ultrasonography in order to preserve it inside the liver. The further parenchymal transection was performed following the demarcation lines. In all recipient operations, hepatic artery reconstruction was performed under microscopy. Biliary reconstruction was performed using Roux-en-Y hepaticojejunostomy. LDLT was performed by 3 experienced surgeons (M.K., S.S., and A.F.) following a standardized surgical procedure. 
| Study variables
The following clinical data were collected from electronic medical re- 
| Assessment of the graft regeneration
The percent ratio of graft volume (GV) to standard liver volume (SLV) (GV/SLV [%]) was assessed at 1 month, 3 months, and 1 year after LDLT. A volume of 1 cm 3 of the liver was assumed to be 1 g.
14 Volumetry was performed by one of the authors (R.I.).
| Statistical analysis
Continuous variables were summarized as medians and ranges and then compared with Wilcoxon rank-sum test. Categorical variables were summarized as frequencies and percentages and compared using the chi-square test. Overall and graft survival curves were estimated using the Kaplan-Meier method and compared with the log-rank test. Areas under receiver operating characteristic curves for mortality were used to determine the optimal cutoff values for PELD score, recipient age, and BW. Prognostic factors for graft loss were identified using univariate and multivariate Cox proportional hazards models and only pretransplant factors were included in the multivariate analyses. Significant confounding factors were selected by multivariate Cox regression analyses with backward elimination (P < .05), keeping the variable of interest (graft type) in the model.
All reported P values are 2-sided, with a value of 0.05 considered statistically significant. All analyses were done using SPSS software ver. 21 (IBM SPSS, Chicago, IL). Table 1 shows the characteristics of the 89 LDLT patients who re- group than in the NAR-LLS graft group (2.4% vs 27.7%, P = .001).
| RE SULTS
| Patient characteristics
| Surgical outcomes and postoperative complications
Median percent change in the PV flow rate was significantly lower in the NAR-LLS graft group than in the reduced-thickness LLS graft group (−26.9% vs 23.5%, P = .003). Operation time, estimated GRWR, and actual GRWR did not differ significantly between the groups. Table 3 shows the incidence of postoperative complications between the reduced-thickness LLS graft group and the NAR-LLS group. Incidence of these complications was significantly lower in the reduced-thickness LLS graft group than in the NAR-LLS graft group (23.8% vs 48.9%, P = .017). Incidence of biliary and vascular complications did not differ significantly between the groups, whereas incidence of postoperative bacteremia was significantly lower in the reduced-thickness LLS graft group (11.9% vs 44.7%, P = .001). Regarding the serum parameters, bilirubin and PT-INR on postoperative day (POD) 14 and 28 were significantly lower in the reduced-thickness LLS graft group than in the NAR-LLS graft group.
In addition, the reduced-thickness LLS graft group had shorter median duration of ventilator weaning (1 day vs 8 days, P = .001), ICU stay (11.5 days vs 28 days, P < .001), and hospital stay (45 days vs 57 days, P = .024). There were no cases of hepatic arterial thrombosis or hepatic venous outflow obstruction in either group.
In donors, perioperative parameters did not differ significantly between the groups. 
| Details of cases with mortality or graft loss with a reduced LLS graft
| Long-term outcomes after LDLT using a reduced LLS graft
During a median follow-up of 4.3 years, patient survival rate was 97.6% in the reduced-thickness LLS graft group and 83.0% in the NAR-LLS graft group at 1 year and 95.1% and 80.9%, respectively, at 3 years. The corresponding graft survival rate was 95.2% and 74.5% at 1 year and 92.4% and 72.3% at 3 years. Patient survival (P = .045, Figure 5A ) and graft survival (P = .014, Figure 5B ) were significantly better in the reduced-thickness LLS graft group than in the NAR-LLS graft group. significant differences in patient survival (P = .309) or graft survival (P = .863) between the groups. Figure 6 shows serial changes of GV/SLV in recipients after LDLT.
| Subgroup analysis in the reduced-thickness LLS graft group
| Graft regeneration in CT volumetry after LDLT
Volumetric data of grafts were available for 13 recipients (NAR-LLS graft: 8; subsegment 2 graft: 3; modified S2 graft: 2) at 1 month, 27
recipients (NAR-LLS graft: 14; subsegment 2 graft: 4; modified S2 graft: 9) at 3 months, and 8 recipients (NAR-LLS graft: 4; subsegment 2 graft: 2; modified S2 graft: 2) at 1 year after LDLT. GV/SLV increased rapidly within 1 month, and GV converged toward the SLV at 1 year after LDLT (Figure 6 ). 
| Prognostic factors for graft survival following LDLT using a reduced LLS graft
| D ISCUSS I ON
In this study of our 10-year experience with 89 pediatric LDLT recipients who received a reduced LLS graft at a high-volume Japanese institution, we found that LDLT using the reducedthickness LLS graft for small babies was associated with better short-term outcomes and better patient and graft survival than LDLT using the conventional NAR-LLS graft. Furthermore, our Adequate reduction of graft thickness is important for preventing major problems related to large-for-size grafts, such as ACR, acute cellular rejection; AMR, antibody-mediated rejection; BA, biliary atresia; FHF, fulminant hepatic failure; GRWR, graft-to-recipient weight ratio; LC, liver cirrhosis; LDLT, living donor liver transplantation; LLS, left lateral segment; NAR, nonanatomically reduced LLS graft; POD, postoperative day; RSV, respiratory syncytial virus; VOC, veno-occlusive change.
a Patient 11 underwent retransplantation due to graft loss caused by portal vein occlusion and progression of intrapulmonary shunt on POM 8.
vascular complications and graft dysfunction due to graft compression or inadequate blood flow. 2 The thickness of an NAR-LLS graft cannot be reduced adequately for LDLT because the thick portion remains in the umbilical fissure. 15 In contrast, S2 is more likely to be suitable for small infants or neonates with a narrow abdominal cavity. In this study, the incidence of primary abdominal closure was lower and PV flow after abdominal closure was significantly decreased in the NAR-LLS graft group than in the reduced-thickness LLS graft group. We consider that the thinness of the S2 graft itself or using the modified S2 graft reduction technique enabled us to perform primary abdominal closure without graft or vascular compression.
Another expected advantage of using the reduced-thickness LLS graft is to decrease infections, including abdominal wall Bold type indicates statistically significant differences. PELD, pediatric end-stage liver disease; WIT, warm ischemic time; CIT, cold ischemic time; GRWR, graft-to-recipient weight ratio; PV, portal vein.
TA B L E 5
Comparison of perioperative outcomes between subsegment 2 graft and modified S2 graft groups infections and respiratory complications leading to delayed extubation. 9, 11 In this study, the lower incidence of abdominal skin clo- Although there were no significant differences in the graft regeneration rate within each graft type, the technique of modified reduction of LLS graft thickness that we have been using at our center has some advantages. First, the ventral part of S3 can be removed without extensive dissection at the umbilical fissure. Srinivasan et al reported that liver transplantation with an S2 graft appears to be more technically challenging and riskier than that with an S3 graft, 4 and thus the major concern of living donor hepatectomy involving an S2 graft is injury to the portal pedicle because of the need for dissection at the base of the umbilical fissure. 16 To prevent injury due to misunderstanding of the vessel branches, routine precise preoperative planning using 3-dimensional fusion CT images is needed.
17
Second, we never compromise outflow of the graft as long as P3 is preserved: we do this by keeping the cutting plane horizontally just above P3, because the main left hepatic vein normally runs between the S2 branch of the PV (P2) and P3 ( Figure 3C ). In contrast, during transection of the subsegment 2 graft, surgeons must take care to avoid injury to the left hepatic vein. Third, in case of biliary stricture after LDLT, preservation of P2 and P3 makes accessibility for radiological intervention easier. 18 The present study shows outcomes in the modified S2 group comparable with those in the subsegment 2 graft group. Especially in the LDLT setting, it is essential to avoid potential risks of graft injury without compromising donor safety. We believe that our modified reduction technique is a safer and more feasible procedure for transplant surgeons than the segment 2 graft and has the potential to provide improved outcomes with lower vascular and biliary complication rates.
In this study, GV in reduced LLS grafts increased rapidly within 1 month after LDLT and converged toward the SLV of recipients with time. Our findings are comparable with those reported in a previous study. 19 It has also been reported that a significant decrease in
Glisson density as well as an increase in hepatic acinus area was found in biopsy specimens from noncirrhotic individuals with 2 consecutive hepatectomies. 20 Although it is difficult to show that these findings of remnant liver after hepatectomy are applicable to liver transplantation settings, this study suggests that the number of Glissonian sheaths may not increase after monosegmental graft transplantation, which may compromise future bile excretion capacity. From this point of view, we therefore believe that our modified reduction technique, with preservation of P3, is a rational approach. Further accumulation of cases with reduced-thickness LLS graft and longer observation periods is necessary to clarify these clinical impacts.
This study had certain limitations. First, although the sample size for LDLT using reduced LLS grafts was large, all patients were from a single institution, leading to potential selection biases including race, graft type, indications for surgery, and surgical techniques. Second, this study was retrospective in design, and thus perioperative data should be interpreted with caution. Specifically, we must admit that the lower amount of blood loss in the NAR-LLS graft group compared with the reduced-thickness LLS graft might be partially because of the initial learning curve of surgical techniques. In addition, the period performed LDLT may partially affect outcomes because of retrospective study design. Ideally, a well-defined, nationwide, prospective study is needed to accurately evaluate independent risk factors for outcomes after LDLT.
In conclusion, this study demonstrated that LDLT using the reduced-thickness LLS graft is a safe and feasible option with better short-and long-term outcomes for small children compared with using the conventional NAR-LLS graft. Although longer-term observation is needed to collect further data, we believe that this technical innovation will extend the applicability of LDLT and offer improved outcomes. TA B L E 6 Univariate and multivariate analysis of risk factors for graft loss following LDLT using a reduced LLS graft 
